Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

14.52 +2.17 (+17.57%)

Delayed Quote Updated: 12:02 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Want $10,000? Invest $1,000 in These 3 Penny Stocks Now ↗

May 07, 2024

Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities.

Via InvestorPlace

Ginkgo Bioworks: Buy, Sell, or Hold? ↗

April 30, 2024

This company has a long way to go before investors will see rewards.

Via The Motley Fool

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? ↗

April 30, 2024

Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.

Via InvestorPlace

Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock? ↗

April 29, 2024

DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze.

Via InvestorPlace

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

Looking Into Ginkgo Bioworks Holdings's Recent Short Interest ↗

April 26, 2024

Via Benzinga

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks. ↗

April 15, 2024

The collaboration could help solve challenges for both businesses.

Via The Motley Fool

What's Going On With Ginkgo Bioworks Stock? ↗

April 11, 2024

Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agreement that initially is contemplated to run over five years.Ginkgo said the...

Via Benzinga

Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗

April 09, 2024

These stocks, a bargain today, are players to hold on to for the long term.

Via The Motley Fool

Is Ginkgo Bioworks Stock a Buy? ↗

March 15, 2024

There's a lot to like about this business, but it's still a risky bet.

Via The Motley Fool

Why Ginkgo Bioworks Stock Is Sinking Today ↗

March 01, 2024

There wasn't much to like in Ginkgo's Q4 update.

Via The Motley Fool

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Earnings Outlook For Ginkgo Bioworks Holdings ↗

February 28, 2024

Via Benzinga

The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation ↗

April 08, 2024

They might not be profitable yet, but they're swinging for the fences.

Via The Motley Fool

Topics Artificial Intelligence

2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? ↗

April 03, 2024

These stocks could rocket higher, but they also present significant risks.

Via The Motley Fool

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 28, 2024

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...

Via Benzinga

Is Ginkgo Bioworks Stock a Buy Now? ↗

February 24, 2024

Ginkgo Bioworks says it is experiencing strong growth from its biopharma customers.

Via The Motley Fool

Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms

March 19, 2024

Via AB Newswire

Topics Supply Chain

3 Pharmaceutical Stocks to Buy Hand Over Fist in March ↗

March 11, 2024

There are some great companies at attractive prices in the lucrative pharmaceutical space.

Via The Motley Fool

Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks? ↗

March 03, 2024

It isn't ready for membership today, but it could have a path in the future.

Via The Motley Fool

S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday? ↗

March 01, 2024

March began on a high note on Wall Street, with tech stocks driving indices to record levels. Despite weak data and mixed Fed remarks, investors remain optimistic. Semiconductor industry continues to...

Via Benzinga

Topics Economy Stocks

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 01, 2024

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Via Benzinga

Why Ginkgo Bioworks Stock Is Down After Earnings ↗

March 01, 2024

Ginkgo said the decrease in sales was primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity segment and the impact of Cell Engineering downstream value share from equity...

Via Benzinga

Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

March 01, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday.

Via Benzinga

Topics Stocks

bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network

February 28, 2024

From bit.bio

Via Business Wire

2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value ↗

February 23, 2024

These two businesses have viable paths to making investors richer -- possibly soon.

Via The Motley Fool

7 Stocks Cathie Wood Is Still Loading Up On in Q1 ↗

February 13, 2024

You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.

Via InvestorPlace

2 Cathie Wood Stocks With Jaw-Dropping Growth Potential ↗

February 08, 2024

These two platform biotechs could revolutionize the field of biologically based products.

Via The Motley Fool

Cathie Wood Just Bought These 3 Biotech Stocks. Should You? ↗

February 07, 2024

They aren't all long shots, but they're all innovative.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.